Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New scan could spot hidden cancers without a biopsy

NCT ID NCT06224309

First seen Jun 06, 2026 · Last updated Jun 17, 2026 · Updated 3 times

Summary

This study tested a new radioactive tracer called 18F-BL40, used in PET/CT scans, to see if it can better detect certain blood cancers like lymphoma and multiple myeloma. Ten adults with these cancers received two scans—one with the new tracer and one with a standard tracer—to compare how well each finds tumors. The goal is to improve cancer detection and monitoring without needing invasive biopsies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • BC Cancer

    Vancouver, British Columbia, V5Z4E6, Canada

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia chronic lymphocytic leukemia/small lymphocytic lymphoma diffuse large B-cell lymphoma Lymphoma, B-Cell, Marginal Zone mantle cell lymphoma marginal zone lymphoma plasma cell myeloma Waldenstrom macroglobulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.